Page last updated: 2024-11-04

5-bromo-5-nitro-1,3-dioxane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-bromo-5-nitro-1,3-dioxane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1807
CHEMBL ID3185787
SCHEMBL ID97282
SCHEMBL ID17347337
MeSH IDM0546458

Synonyms (41)

Synonym
AKOS015834980
5-bromo-5-nitro-1,3-dioxane
1,3-dioxane, 5-bromo-5-nitro-
5-brom-5-nitro-1,3-dioxan [german]
m-dioxane, 5-bromo-5-nitro-
brn 4668673
5-bromo-5-nitro-m-dioxane
einecs 250-001-7
bronidox
5-bromo-5-nitro-1,3-dioxane, >=99%
B3156
30007-47-7
NCGC00255969-01
tox21_301588
dtxsid1044560 ,
cas-30007-47-7
dtxcid9024560
B3769
u184i9qbnm ,
unii-u184i9qbnm
5-brom-5-nitro-1,3-dioxan
FT-0620143
5-bromo-5-nitro-1,3-dioxane [inci]
microcide i
SCHEMBL97282
SCHEMBL17347337
Q-200534
XVBRCOKDZVQYAY-UHFFFAOYSA-N
bronidox l
CHEMBL3185787
mfcd00101855
5-bromo-5-nitro-1,3-dioxane, analytical standard
Q4973879
AS-15941
CS-W015032
SY014363
D88989
HY-W014316
PD053603
EN300-7381687
AKOS040744440
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (22)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency25.18460.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency70.97990.002541.796015,848.9004AID1347398
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency54.94103.189029.884159.4836AID1224846; AID1224894
RAR-related orphan receptor gammaMus musculus (house mouse)Potency23.43750.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency43.27710.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency61.22470.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency56.09680.001022.650876.6163AID1224838; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency56.56880.000214.376460.0339AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.76600.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency39.15330.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency57.76480.001530.607315,848.9004AID1224848; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency68.58960.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency86.92210.000229.305416,493.5996AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency48.96620.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency48.96620.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.63790.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency44.34580.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259395
activating transcription factor 6Homo sapiens (human)Potency54.94100.143427.612159.8106AID1159516
Histone H2A.xCricetulus griseus (Chinese hamster)Potency44.98780.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency26.42280.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency54.94100.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.81 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]